Silence Therapeutics Share Price (SLN)

Find Your Broker

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Silence Ther.	LSE:SLN	London	Ordinary Share	GB00B9GTXM62	ORD 5P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-4.70p	-5.22%	85.40p	15,110	16:35:05

Bid Price		Offer Price	High Price	Low Price	Open Price
82.00p		88.80p	91.00p	85.00p	91.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.02	-3.78	-2.30		113.0

Related Shares
AstraZeneca (AZN), GlaxoSmithKline (GSK), Venn Life (VENN), Port Erin (PEBI)

Silence Therapeutics (SLN) Latest News

Silence Therapeutics News

Date	Time	Source	Headline
12/10/2018	17:29	UKREG	Silence Therapeutics PLC Erratum: Results of Placing - Withdrawn
12/10/2018	16:12	UKREG	Silence Therapeutics PLC Results of Placing
11/10/2018	12:27	ALNC	US Patent Board Rejects Alnylam's Claim Against Silence Therapeutics
11/10/2018	09:43	ALNCF	Alliance News Flash Headline
11/10/2018	09:14	UKREG	Silence Therapeutics PLC PTAB Upholds Silence Patent
10/10/2018	10:49	ALNC	Silence Therapeutics Files Interim Injunction Against Alnylam
10/10/2018	06:00	UKREG	Silence Therapeutics PLC New divisional patent and injunction application
05/10/2018	13:16	UKREG	Silence Therapeutics PLC Holding(s) in Company
26/9/2018	06:01	RNSNON	Silence Therapeutics PLC Silence to Present at Healthcare Conference
21/9/2018	13:19	UKREG	Silence Therapeutics PLC Additional Listing

More Silence Therapeutics News

Silence Therapeutics Takeover Rumours

Silence Therapeutics (SLN) Share Charts

1 Year Silence Therapeutics Chart

1 Month Silence Therapeutics Chart

Intraday Silence Therapeutics Chart

Silence Therapeutics (SLN) Discussions and Chat

Silence Therapeutics Forums and Chat

Date	Time	Title	Posts
20/11/2018	13:01	Silence Therapeutics (the old SR Pharma)	47,630
06/10/2016	08:04	Gower Productions Presents ....."PREDICTA BID"	52
05/10/2016	19:29	port	-
29/5/2013	09:32	Silence Therapeutics - news and views	1,412
15/2/2013	08:57	SLN - I see no ships, but I do see 10p looming, ahoy!	368

Add a New Thread

Silence Therapeutics (SLN) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-11-20 14:58:06	85.00	2,500	2,125.00	AT
2018-11-20 14:50:44	86.00	2,710	2,330.60	O
2018-11-20 14:50:37	86.00	2,500	2,150.00	AT
2018-11-20 13:03:33	88.00	2,000	1,760.00	AT
2018-11-20 13:03:33	90.00	1,500	1,350.00	AT

View all Silence Therapeutics trades in real-time

Silence Therapeutics (SLN) Top Chat Posts

Date	Subject
20/11/2018 08:20	Silence Therapeutics Daily Update: Silence Ther. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SLN. The last closing price for Silence Therapeutics was 90.10p. Silence Ther. has a 4 week average price of 85p and a 12 week average price of 85p. The 1 year high share price is 209p while the 1 year low share price is currently 85p. There are currently 132,322,452 shares in issue and the average daily traded volume is 50,334 shares. The market capitalisation of Silence Ther. is £113,003,374.01. Read Full Thread Reply
20/11/2018 08:36	callumross: Well, there is certainly plenty newsflow expected in the next 6 weeks to drive the share price up (or down!). To recap, Quark phase 3 results, High Court case against Alnylam commencing and application for phase 1 trial. Read Full Thread Follow Reply
05/10/2018 16:37	1gw: Interesting to compare the shares on loan position with the share price chart. According to Euroclear, SoL monthly average this year is as follows: 1.4m Jan (average shares on loan) 1.4m Feb 2.6m Mar 4.3m Apr 4.2m May 4.2m Jun 4.1m Jul 3.9m Aug 2.3m Sep So it looks like a significant increase in short positions in March and April (assuming the SoL correlates to short positions) may have helped to knock the shareprice off its 200p perch. hTtps://my.euroclear.com/apps/en/monthly-stock-loan-data.html#month=eq:9&year=eq:2018&limit=0&search=1&order=asc:abbreviation Read Full Thread Follow Reply
03/8/2018 13:10	tshirley12: Could anyone tell me what has happened in the last couple of weeks for the share price to have dropped about 40 points,or nearly 25%. Read Full Thread Follow Reply
06/3/2018 08:32	1gw: I missed the Nasdaq reference at first glance. Interesting. I get the impression this is a management team with more than half an eye focused on the share price and the potential to support the price with the carefully managed release of information. Read Full Thread Follow Reply
04/12/2017 08:30	1gw: Nice bit of profit-taking on the arwr stake. I wonder what that will do to the arwr share price today? And whether it's all part of the game to get some meaningful dialogue going with arwr? Read Full Thread Follow Reply
28/9/2017 07:23	rogen83: Arrowhead stake now worth £20m or 30p of SLNs share price Good work Ali Read Full Thread Follow Reply
07/9/2017 13:36	1gw: It has at least put the brakes on the share price. Who knows - if there's any truth to the suggestions that Alnylam might look to settle the patent dispute by taking over Silence then now might be a good time to strike. Certainly it seemed to me from the Alnylam call that Alnylam see the Fitusiran death as tragic but by no means an end to their hopes for the drug. Read Full Thread Follow Reply
24/8/2017 14:24	1gw: I can't help feeling there's an element of SLN investors looking at the ARWR price trajectory and thinking something's happening - and ARWR investors looking at the SLN price trajectory and thinking the same. Hopefully there's some substance behind both moves rather than mutually reinforcing illusions... Read Full Thread Follow Reply
21/8/2017 15:19	1gw: I am surprised we haven't had a rush of short-term players to the bulletin boards, given the share price chart. All the better for the future, perhaps, if the share price has done what it has done without much input from the bulletin boards or twitter. Read Full Thread Follow Reply
04/5/2017 15:00	1gw: ARWR is up around 20% this afternoon - not enough to take me into profit on my holding, but makes the loss look a little less severe. They beat on revenue and earnings, thanks (I think) to the Amgen up-front payments, and also announced an analyst R&D day for September to explain what they're doing. They described the Amgen partnership as working well and said in response to a question that they were interested in similar partnerships with other companies and are optimistic that they can enter into additional strategic partnerships. No obvious follow-through to the SLN share price yet, but perhaps ARWR's spike (on heavy volume) will draw some attention to other companies in the sector. Read Full Thread Follow Reply

Silence Therapeutics share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:42 V: D:20181121 05:26:54